Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:alternativeTo |
Heart transplant
|
| gptkbp:approvedBy |
gptkb:FDA
2004 |
| gptkbp:canBe |
Temporary
Permanent Bridge to transplant Destination therapy |
| gptkbp:category |
Cardiovascular device
Implantable device |
| gptkbp:complication |
Stroke
Infection Blood clot |
| gptkbp:cost |
Hundreds of thousands of dollars
|
| gptkbp:countryOfFirstImplant |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Paul_Winchell
gptkb:Robert_Jarvik |
| gptkbp:firstImplanted |
1982
|
| gptkbp:firstPatient |
gptkb:Barney_Clark
|
| https://www.w3.org/2000/01/rdf-schema#label |
Artificial Heart
|
| gptkbp:lifespan |
Several months to years
|
| gptkbp:limitation |
Limited mobility
Risk of device failure |
| gptkbp:maintenance |
Regular medical follow-up
|
| gptkbp:material |
Titanium
Polyurethane |
| gptkbp:monitors |
cardiologist
Surgeon |
| gptkbp:notableModel |
gptkb:Jarvik-7
gptkb:SynCardia_Total_Artificial_Heart |
| gptkbp:notRecommendedFor |
Patients with irreversible organ failure
Patients with severe infection |
| gptkbp:patent |
gptkb:Paul_Winchell
|
| gptkbp:patentedYear |
1963
|
| gptkbp:provides |
gptkb:battery
External power source |
| gptkbp:relatedTo |
gptkb:Pacemaker
Ventricular assist device |
| gptkbp:requires |
Anticoagulation therapy
Hospitalization for implantation |
| gptkbp:riskFactor |
Bleeding
Immune response Device malfunction |
| gptkbp:size |
Similar to human heart
|
| gptkbp:suitableFor |
End-stage heart failure patients
|
| gptkbp:surgeryType |
Open-heart surgery
|
| gptkbp:usedFor |
Pumping blood
Replacing biological heart |
| gptkbp:usedIn |
Cardiac surgery
|
| gptkbp:weight |
About 1 kg
|
| gptkbp:bfsParent |
gptkb:Jonathan_Coulton
|
| gptkbp:bfsLayer |
6
|